Sort by
Refine Your Search
-
this will involve the development of novel ML/DL methods which leverage both computational and experimental data. Candidates should also have experience of numerical modelling (e.g. CFD and FEA), working as
-
. The project seeks to develop mathematical models for allocation of critical resources during pandemics. Populating these instances with real-world data we would then develop novel algorithms to solve them
-
modeling of the data. The successful applicant will join a vibrant research group that uses a wide variety of spectroscopic methods to study photochemical processes. Essential Duties and Responsibilities
-
We are seeking a highly motivated Postdoctoral Research Associate in the field of Theoretical and Computational Chemistry to develop accurate models of time-resolved X-ray photoelectron spectroscopy
-
to gender—and demonstrated expertise in advanced statistical methods (e.g., multilevel modelling). The successful candidate will work closely with the Principal Investigator, Dr. Verena Klein, a PhD student
-
, German Research Foundation. The selected candidate would conduct research at the interface of theory and application. The project seeks to develop mathematical models for allocation of critical resources
-
Computational Chemistry to develop accurate models of time-resolved X-ray photoelectron spectroscopy (TRXPS) experiments of gas phase molecules. The successful candidate will be based in Southampton and work in
-
. The project will involve experiments at Free Electron Laser Facilities and subsequent analysis and modeling of the data. The successful applicant will join a vibrant research group that uses a wide variety of
-
and environment can be part of the role, including performing in vitro and, where necessary, in vivo (animal models) studies in preparation of potential first-human studies. For this purpose, there will
-
(animal models) studies in preparation of potential first-human studies. For this purpose, there will be a tight interaction between the Cancer B-cell group and Prof. Mark Cragg at the Antibody Vaccine